Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

HHS Logo Eagle IconU.S. Department of Health and Human Services
napa

Advisory Council January 2021 Meeting Presentation: Risk Reduction Goal

ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES

Monday, January 25, 2021

Printer Friendly Version in PDF Format (3 PDF pages)

 

Risk Reduction Goal: Updates

Lisa C. McGuire, PhD
Centers for Disease Control and Prevention
National Center for Chronic Disease Prevention and Health Promotion
Division of Population Health

Risk Reduction Goal

  • To develop a national goal to reduce the burden of risk factors in order to prevent or delay onset of Alzheimer's disease and related dementias (ADRD)
    1. Establish a subcommittee to address risk factor reduction to mitigate the public health burden of ADRD. Over the next year, the subcommittee should determine specific goals, metrics, and timelines and provide updates at the quarterly Advisory Council meetings.
    2. Review existing data on risk reduction and explore setting metrics for monitoring public health impact using a rigorous, open, and transparent process.
    3. Coordinate and seek broad input from experts and individuals at risk for or with symptomatic ADRD to inform the subcommittee recommendations.
    4. Identify opportunities for facilitating risk reduction across the spectrum of ADRD research, clinical care, and long-term services and supports (LTSS).
    5. CDC should develop a National Center of Public Health Excellence on Risk Reduction.

Steering Committee

Matthew Baumgart
Vice President of Health Policy
Alzheimer's Association

Lisa C. McGuire, Ph.D.
Lead, Alzheimer's Disease and Healthy Aging Program
Lead, Arthritis Science Team
Centers for Disease Control and Prevention

Kelly O'Brien
Executive Director of the Brain Health Ecosystem project
UsAgainstAlzheimer's

Subcommittee Membership

  • Steering and Subcommittee Advisor: Alan Levey, NAPA co-chair
  • Expertise Areas:
    • Public Health
    • Clinical Care
    • Innovation/Industry
    • Research
  • Selection Considerations: two members from each expertise areas were invited to serve as subcommittee members based on the following:
    • Multi-disciplinary, action-oriented, and diverse candidates
    • Those with a history of working within the field (e.g., clinician, academic)
    • Range of experiences and representation from fields of aging, cardiovascular disease, and other primary risk factor areas of ADRD

Process and Timeline

  • Process (November 2020 - August 2021)
    1. Steering Committee
      • Establish steering committee
      • Establish subcommittee
    2. Subcommittees
      • Develop initial recommendations
      • Form Workgroups (subset of risk factors)
        • Science, clinical intervention, and public health action
        • Technical guidance for national risk reduction goal
    3. Steering committee reviews and revises recommendations
    4. Recommendations sent to reviewers
    5. Recommendations presented to NAPA Advisory Council
  • How to get involved as a reviewer: aging@cdc.gov

THANK YOU

Lisa McGuire, PhD
LMCGUIRE@CDC.GOV